FP-1770

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameFP-1770
Drug Alias NameFP1770
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor agonists
TargetsMetabotropic glutamate receptor
Therapy Area/IndicationsSchizophreniaDepressive Disorder, MajorAnxiety Disorders +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDomain Therapeutics SA
Active IndicationsN/A
Inactive IndicationsSchizophreniaDepressive Disorder, MajorAnxiety Disorders +[5

Other Information

ATC CodeN/A
Related LinksN/A